In this year’s 13th edition of the TOP100 Swiss Startup Award, CUTISS has been recognized as a ‘most promising’ TOP 25 scale-up.
We are just as proud to say that CUTISS continues to place 1st in the Biotech category, this year amongst the scale ups!
For this year’s listing, CUTISS was selected by a jury of 25 growth investors alongside other companies that are five to ten years old and therefore considered as ‘scale ups’. We want extend a big thank you to everyone on our team, our investors and supporters, and partners! Since our company’s founding in 2017, we continue to accomplish significant milestones.
CUTISS has featured consistently in the TOP100 awards. As a start-up (up to five years old) we won the award and placed 1st in 2020, we came 2nd in 2021, and in 2022 we placed 4th amongst the 100 contenders. CUTISS has consistently ranked first amongst biotechs.
Further details about the awards and rankings are available in the link below.
